OPHTHALMIC COMPOSITIONS COMPRISING LATANOPROST FOR USE IN THE TREATMENT OF OCULAR DISEASES
The invention provides a pharmaceutical composition for use in the prevention or therapy of glaucoma, increased intraocular pressure, ocular hypertension and/or a symptom associated therewith, wherein - the composition comprises latanoprost and a liquid vehicle comprising a semifluorinated alkane; a...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | EICKHOFF, KIRSTEN GUNTHER, BERNHARD LOSCHER, FRANK |
| description | The invention provides a pharmaceutical composition for use in the prevention or therapy of glaucoma, increased intraocular pressure, ocular hypertension and/or a symptom associated therewith, wherein - the composition comprises latanoprost and a liquid vehicle comprising a semifluorinated alkane; and - the composition is administered to the eye of a subject; and - the amount of latanoprost administered in a single dose per eye is in the range of from about 0.5 to 1.4 µg.
L'invention concerne une composition pharmaceutique destinée à être utilisée dans la prévention ou le traitement du glaucome, d'une augmentation de la pression intraoculaire, d'une hypertension oculaire et/ou d'un symptôme associé à ces derniers, la composition comprenant du latanoprost et un véhicule liquide comprenant un alcane semi-fluoré ; la composition étant administrée au niveau de l'il d'un patient ; et la quantité de latanoprost administrée en une seule dose par il se situant dans une plage comprise environ entre 0,5 et 1,4 µg. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA3076776A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA3076776A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA3076776A13</originalsourceid><addsrcrecordid>eNqNykEKwkAMQNHZuBD1DrmAoBTadZhmnEA7KZN046YUGVeihXp_BPEArj4P_tZdZYgWsevZg5d-EGVjSfpFZuV0gQ4NkwxZ1CBIhlEJOIFFAsuE1lMykADixw4ztKyESrp3m_v8WMvh152DQObjsSyvqazLfCvP8p48Vqembpoaz9Ufywc2ETG9</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>OPHTHALMIC COMPOSITIONS COMPRISING LATANOPROST FOR USE IN THE TREATMENT OF OCULAR DISEASES</title><source>esp@cenet</source><creator>EICKHOFF, KIRSTEN ; GUNTHER, BERNHARD ; LOSCHER, FRANK</creator><creatorcontrib>EICKHOFF, KIRSTEN ; GUNTHER, BERNHARD ; LOSCHER, FRANK</creatorcontrib><description>The invention provides a pharmaceutical composition for use in the prevention or therapy of glaucoma, increased intraocular pressure, ocular hypertension and/or a symptom associated therewith, wherein - the composition comprises latanoprost and a liquid vehicle comprising a semifluorinated alkane; and - the composition is administered to the eye of a subject; and - the amount of latanoprost administered in a single dose per eye is in the range of from about 0.5 to 1.4 µg.
L'invention concerne une composition pharmaceutique destinée à être utilisée dans la prévention ou le traitement du glaucome, d'une augmentation de la pression intraoculaire, d'une hypertension oculaire et/ou d'un symptôme associé à ces derniers, la composition comprenant du latanoprost et un véhicule liquide comprenant un alcane semi-fluoré ; la composition étant administrée au niveau de l'il d'un patient ; et la quantité de latanoprost administrée en une seule dose par il se situant dans une plage comprise environ entre 0,5 et 1,4 µg.</description><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2019</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190404&DB=EPODOC&CC=CA&NR=3076776A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190404&DB=EPODOC&CC=CA&NR=3076776A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>EICKHOFF, KIRSTEN</creatorcontrib><creatorcontrib>GUNTHER, BERNHARD</creatorcontrib><creatorcontrib>LOSCHER, FRANK</creatorcontrib><title>OPHTHALMIC COMPOSITIONS COMPRISING LATANOPROST FOR USE IN THE TREATMENT OF OCULAR DISEASES</title><description>The invention provides a pharmaceutical composition for use in the prevention or therapy of glaucoma, increased intraocular pressure, ocular hypertension and/or a symptom associated therewith, wherein - the composition comprises latanoprost and a liquid vehicle comprising a semifluorinated alkane; and - the composition is administered to the eye of a subject; and - the amount of latanoprost administered in a single dose per eye is in the range of from about 0.5 to 1.4 µg.
L'invention concerne une composition pharmaceutique destinée à être utilisée dans la prévention ou le traitement du glaucome, d'une augmentation de la pression intraoculaire, d'une hypertension oculaire et/ou d'un symptôme associé à ces derniers, la composition comprenant du latanoprost et un véhicule liquide comprenant un alcane semi-fluoré ; la composition étant administrée au niveau de l'il d'un patient ; et la quantité de latanoprost administrée en une seule dose par il se situant dans une plage comprise environ entre 0,5 et 1,4 µg.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2019</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNykEKwkAMQNHZuBD1DrmAoBTadZhmnEA7KZN046YUGVeihXp_BPEArj4P_tZdZYgWsevZg5d-EGVjSfpFZuV0gQ4NkwxZ1CBIhlEJOIFFAsuE1lMykADixw4ztKyESrp3m_v8WMvh152DQObjsSyvqazLfCvP8p48Vqembpoaz9Ufywc2ETG9</recordid><startdate>20190404</startdate><enddate>20190404</enddate><creator>EICKHOFF, KIRSTEN</creator><creator>GUNTHER, BERNHARD</creator><creator>LOSCHER, FRANK</creator><scope>EVB</scope></search><sort><creationdate>20190404</creationdate><title>OPHTHALMIC COMPOSITIONS COMPRISING LATANOPROST FOR USE IN THE TREATMENT OF OCULAR DISEASES</title><author>EICKHOFF, KIRSTEN ; GUNTHER, BERNHARD ; LOSCHER, FRANK</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA3076776A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2019</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>EICKHOFF, KIRSTEN</creatorcontrib><creatorcontrib>GUNTHER, BERNHARD</creatorcontrib><creatorcontrib>LOSCHER, FRANK</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>EICKHOFF, KIRSTEN</au><au>GUNTHER, BERNHARD</au><au>LOSCHER, FRANK</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>OPHTHALMIC COMPOSITIONS COMPRISING LATANOPROST FOR USE IN THE TREATMENT OF OCULAR DISEASES</title><date>2019-04-04</date><risdate>2019</risdate><abstract>The invention provides a pharmaceutical composition for use in the prevention or therapy of glaucoma, increased intraocular pressure, ocular hypertension and/or a symptom associated therewith, wherein - the composition comprises latanoprost and a liquid vehicle comprising a semifluorinated alkane; and - the composition is administered to the eye of a subject; and - the amount of latanoprost administered in a single dose per eye is in the range of from about 0.5 to 1.4 µg.
L'invention concerne une composition pharmaceutique destinée à être utilisée dans la prévention ou le traitement du glaucome, d'une augmentation de la pression intraoculaire, d'une hypertension oculaire et/ou d'un symptôme associé à ces derniers, la composition comprenant du latanoprost et un véhicule liquide comprenant un alcane semi-fluoré ; la composition étant administrée au niveau de l'il d'un patient ; et la quantité de latanoprost administrée en une seule dose par il se situant dans une plage comprise environ entre 0,5 et 1,4 µg.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_CA3076776A1 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| title | OPHTHALMIC COMPOSITIONS COMPRISING LATANOPROST FOR USE IN THE TREATMENT OF OCULAR DISEASES |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T08%3A38%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=EICKHOFF,%20KIRSTEN&rft.date=2019-04-04&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA3076776A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |